ZA845397B - Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them - Google Patents

Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them

Info

Publication number
ZA845397B
ZA845397B ZA845397A ZA845397A ZA845397B ZA 845397 B ZA845397 B ZA 845397B ZA 845397 A ZA845397 A ZA 845397A ZA 845397 A ZA845397 A ZA 845397A ZA 845397 B ZA845397 B ZA 845397B
Authority
ZA
South Africa
Prior art keywords
pyrrolidinones
active
preparation
nervous system
central nervous
Prior art date
Application number
ZA845397A
Other languages
English (en)
Inventor
Kathleen Biziere
Jean-Pierre Chambon
Jean-Charles Molimard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA845397B publication Critical patent/ZA845397B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA845397A 1983-07-12 1984-07-12 Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them ZA845397B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8311636A FR2549053B1 (fr) 1983-07-12 1983-07-12 Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant

Publications (1)

Publication Number Publication Date
ZA845397B true ZA845397B (en) 1985-02-27

Family

ID=9290775

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA845397A ZA845397B (en) 1983-07-12 1984-07-12 Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them

Country Status (23)

Country Link
US (1) US4604383A (no)
EP (1) EP0135406B1 (no)
JP (1) JPS6084265A (no)
KR (1) KR910003362B1 (no)
AR (1) AR240451A1 (no)
AT (1) ATE30150T1 (no)
AU (1) AU560725B2 (no)
CA (1) CA1249593A (no)
DD (2) DD227962A5 (no)
DE (1) DE3466686D1 (no)
DK (1) DK343784A (no)
ES (1) ES8504122A1 (no)
FI (1) FI77848C (no)
FR (1) FR2549053B1 (no)
GR (1) GR81502B (no)
HU (1) HU192564B (no)
IL (1) IL72324A (no)
NO (1) NO163617C (no)
NZ (1) NZ208865A (no)
PT (1) PT78874B (no)
SU (1) SU1391497A3 (no)
YU (2) YU121384A (no)
ZA (1) ZA845397B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
IE61631B1 (en) * 1988-05-20 1994-11-16 Zambon Spa Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
GB9307431D0 (en) * 1993-04-08 1993-06-02 Oxford Asymmetry Ltd Improvements in or relating to chiral auxiliaries
CN106977415B (zh) * 2016-01-15 2021-03-26 广东东阳光药业有限公司 一种沙库必曲的中间体及其制备方法
EP3424899B1 (en) * 2016-02-29 2022-05-11 Sunshine Lake Pharma Co., Ltd. Sacubitril intermediate and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272842A (en) * 1965-06-25 1966-09-13 Lilly Co Eli Novel pyrrolinones
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
FR2436779A1 (fr) * 1978-09-22 1980-04-18 Pharmindustrie Derives de pyrrolidine-2 methanol utilisables comme medicaments

Also Published As

Publication number Publication date
AU560725B2 (en) 1987-04-16
DD227962A5 (de) 1985-10-02
ATE30150T1 (de) 1987-10-15
FR2549053A1 (fr) 1985-01-18
NO163617B (no) 1990-03-19
PT78874B (fr) 1986-06-02
CA1249593A (en) 1989-01-31
SU1391497A3 (ru) 1988-04-23
DK343784A (da) 1985-01-13
AR240451A1 (es) 1990-04-30
GR81502B (no) 1984-12-11
NZ208865A (en) 1986-12-05
HUT34443A (en) 1985-03-28
FR2549053B1 (fr) 1985-12-27
IL72324A (en) 1987-10-30
HU192564B (en) 1987-06-29
DK343784D0 (da) 1984-07-12
EP0135406B1 (fr) 1987-10-07
US4604383A (en) 1986-08-05
NO842821L (no) 1985-01-14
YU121384A (en) 1986-10-31
FI77848B (fi) 1989-01-31
FI842795A (fi) 1985-01-13
KR910003362B1 (ko) 1991-05-28
PT78874A (fr) 1984-08-01
ES534221A0 (es) 1985-04-16
NO163617C (no) 1990-06-27
KR850001165A (ko) 1985-03-16
DD229121A5 (de) 1985-10-30
IL72324A0 (en) 1984-11-30
FI77848C (fi) 1989-05-10
YU81086A (en) 1986-10-31
DE3466686D1 (en) 1987-11-12
JPS6084265A (ja) 1985-05-13
ES8504122A1 (es) 1985-04-16
FI842795A0 (fi) 1984-07-11
AU3021684A (en) 1985-01-17
EP0135406A1 (fr) 1985-03-27

Similar Documents

Publication Publication Date Title
DE3572488D1 (en) Dialkoxyridines, process for their preparation, their application and medicaments containing them
SG93690G (en) Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them
OA08707A (en) Tertiary hydroxyalkylxanthines, processes for their preparation, medicaments containing them and their use.
IL81184A0 (en) Diarylalkyl-substituted alkylamines,processes for their preparation,their use,and medicaments containing them
DE3368610D1 (en) Phenyl-1-piperidino-2-propanol derivatives, their preparation and medicaments containing them
ZA83743B (en) Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments
ZA875166B (en) New benzenesulphonamidoindanyl compounds,medicaments containing these compounds and processes for their preparation
DE3263462D1 (en) Azepine derivatives, their preparation and medicaments containing them
IL81676A (en) Naphthothiazepinones,their manufacture and medicaments containing them
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
AR242389A1 (es) Procedimiento para preparar -di-(n-alquil c1-c4)-amino-4,5-dihidroimidazo¡1,2-a¿quinazolin-2(1h)-onas.
DK170889A (da) Anvendelse af a1(iii)- eller fe(iii)-chelater til bekaempelse af bloeddyr
DE3464490D1 (en) 1-phenyl-2-aminocarbonyl indoles, their preparation and medicines containing them
DE3368061D1 (en) Azabicycloalkane derivatives, their preparation and medicaments containing them
IL86233A0 (en) Substituted tetrahydrophthalimides,processes for their preparation and herbicides containing them
DE3366355D1 (en) Process for the preparation of catalytically active aluminosilicates, and use thereof
ZA845397B (en) Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them
GR80474B (en) Chinazolinderivatives, method for the preparation thereof, and medicaments containing said compounds
ZA85655B (en) Hydantoin derivatives,process for producing the same and medicine containing the same
EP0042093A3 (en) 4-aralkyl-1,4-dihydropyridines, processes for praparing them, their use as medicines and preparation thereof
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
ZA841331B (en) Medicaments containing muzolimine,their use and processes for their production
ZA886915B (en) 4-azasaccharines,4-aza-dihydro-or-tetrahydro-saccharines and processes for the preparation thereof
DE3167536D1 (en) 3-chloroquinoline derivatives, processes for their preparation and medicaments containing them
EP0301245A3 (en) 3-sulfonyl-3,7-diazabicyclo-(3,3,1)nonane compounds, processes for their preparation, and medicaments containing these compounds